FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sten Holmäng

Research Profile

Disorders

Concepts & Ideas

Geographic Areas

Sweden

Procedures

Anatomy

Chemicals & Drugs

BCG Vaccine

Co-author Network

Publications

TOP 3
Fredrik Liedberg; Börje Ljungberg; Per-Uno Malmstrom; Sten Holmäng; Abolfazl Hosseini; Staffan Jahnson
[Fast measures in macro hematuria are both necessary and possible].
Sten Holmäng; Viveka Ströck
Should follow-up cystoscopy in bacillus Calmette-Guérin-treated patients continue after five tumour-free years?
Fredrik Liedberg; Börje Ljungberg; Per-Uno Malmstrom; Wiking Månsson; Leyla Nunez; Catrin Wessman; Hans Wijkström; Sten Holmäng; Erik Holmberg; Staffan Jahnson
Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: a Swedish population-based survey.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sten Holmäng (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Fredrik Liedberg; Börje Ljungberg; Per-Uno Malmstrom; Sten Holmäng; Abolfazl Hosseini; Staffan Jahnson
[Fast measures in macro hematuria are both necessary and possible].
Läkartidningen 2012;109(20-21):1034-5.
2012: Sten Holmäng; Viveka Ströck
Should follow-up cystoscopy in bacillus Calmette-Guérin-treated patients continue after five tumour-free years?
European urology 2012;61(3):503-7.
2012: Fredrik Liedberg; Börje Ljungberg; Per-Uno Malmstrom; Wiking Månsson; Leyla Nunez; Catrin Wessman; Hans Wijkström; Sten Holmäng; Erik Holmberg; Staffan Jahnson
Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: a Swedish population-based survey.
Scandinavian journal of urology and nephrology 2012;46(1):14-8.
2011: Ross J Miller; Sten Holmäng; Sonny L Johansson; Subodh M Lele
Small cell carcinoma of the renal pelvis and ureter: clinicopathologic and immunohistochemical features.
Archives of pathology & laboratory medicine 2011;135(12):1565-9.
2011: Staffan Jahnson; Dag Sandblom; Sten Holmäng
A randomized trial comparing 2 doses of polidocanol sclerotherapy for hydrocele or spermatocele.
The Journal of urology 2011;186(4):1319-23.
2011: Viveka Ströck; Leif Dotevall; Torsten Sandberg; Christina Kåbjörn Gustafsson; Sten Holmäng
Late bacille Calmette-Guérin infection with a large focal urinary bladder ulceration as a complication of bladder cancer treatment.
BJU international 2011;107(10):1592-7.
2008: Ingela Berrum-Svennung; Torvald Granfors; Staffan Jahnson; Hans Boman; Sten Holmäng
A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences.
The Journal of urology 2008;179(1):101-5; discussion 105-6.
2008: Sten Holmäng; Susanne Amsler-Nordin; Kerstin Carlson; Erik Holmberg; Sonny L Johansson
Completeness and correctness of registration of renal pelvic and ureteral cancer in the Swedish Cancer Registry.
Scandinavian journal of urology and nephrology 2008;42(1):12-7.
2007: Patrik Andius; Sonny L Johansson; Sten Holmäng
Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion.
Urology 2007;70(4):758-62.
2007: Sten Holmäng; Subodh M Lele; Sonny L Johansson
Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.
The Journal of urology 2007;178(1):51-6.
2006: Sten Holmäng; Jean Thomsen; Sonny L Johansson
Micropapillary carcinoma of the renal pelvis and ureter.
The Journal of urology 2006;175(2):463-6; discussion 466-7.
2006: Sten Holmäng; Sonny L Johansson
Impact of diagnostic and treatment delay on survival in patients with renal pelvic and ureteral cancer.
Scandinavian journal of urology and nephrology 2006;40(6):479-84.
2006: Sten Holmäng; Sonny L Johansson
Bilateral metachronous ureteral and renal pelvic carcinomas: incidence, clinical presentation, histopathology, treatment and outcome.
The Journal of urology 2006;175(1):69-72; discussion 72-3.
2005: Patrik Andius; Marianne Fehrling; Sten Holmäng
Intravesical bacillus Calmette-Guèrin therapy: experience with a reduced dwell-time in patients with pronounced side-effects.
BJU international 2005;96(9):1290-3.
2005: Sten Holmäng; Sonny L Johansson
Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system.
Urology 2005;66(2):274-8.
2005: Sten Holmäng; Sonny L Johansson
Tumours of the ureter and renal pelvis treated with resection and renal autotransplantation: a study with up to 20 years of follow-up.
BJU international 2005;95(9):1201-5.
2005: Lennart Aström; Dorte Pedersen; Claes Mercke; Sten Holmäng; Karl-Axel Johansson
Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;74(2):157-61.
2005: Ingela Berrum-Svennung; Sten Holmäng
Routine postoperative urography after cystectomy and urinary diversion is not necessary.
Scandinavian journal of urology and nephrology 2005;39(3):211-3.
2005: Ingela Berrum-Svennung; Hans Hedelin; Sten Holmäng
Costs of radical cystectomy.
Scandinavian journal of urology and nephrology 2005;39(1):36-41.
2004: Sten Holmäng; Sonny L Johansson
Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome.
Cancer 2004;101(4):741-7.
2004: Patrik Andius; Sten Holmäng
Bacillus Calmette-Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression.
BJU international 2004;93(7):980-4.
2004: Patrik Andius; Ole Damm; Sten Holmäng
Prognostic factors in patients with carcinoma in situ treated with intravesical bacille Calmette-Guérin.
Scandinavian journal of urology and nephrology 2004;38(4):285-90.
2002: Hans Boman; Hans Hedelin; Stefan Jacobsson; Sten Holmäng
Newly diagnosed bladder cancer: the relationship of initial symptoms, degree of microhematuria and tumor marker status.
The Journal of urology 2002;168(5):1955-9.
2002: Bo Lennernäs; Sten Holmäng; Hans Hedelin
High-dose rate brachytherapy of prostatic adenocarcinoma in combination with external beam radiotherapy a long-term follow-up of the first 50 patients at one center.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2002;178(10):537-41.
2002: Hans Hedelin; Sten Holmäng; Lena Wiman
The cost of bladder tumour treatment and follow-up.
Scandinavian journal of urology and nephrology 2002;36(5):344-7.
2002: Hans Boman; Hans Hedelin; Sten Holmäng
Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence.
The Journal of urology 2002;167(1):80-3.
2001: Hans Boman; Hans Hedelin; Sten Holmäng
The results of routine evaluation of adult patients with haematuria analysed according to referral form information with 2-year follow-up.
Scandinavian journal of urology and nephrology 2001;35(6):497-501.
2001: Hans Hedelin; Hans Boman; Sten Holmäng
[When is it meaningful to investigate hematuria? Macroscopic hematuria--investigate always. Microscopic hematuria--symptoms and age decide].
Läkartidningen 2001;98(48):5498-500, 5503.
2001: Hans Boman; Hans Hedelin; Sten Holmäng
Urine tissue-polypeptide-specific antigen (TPS) as a marker for bladder cancer.
Scandinavian journal of urology and nephrology 2001;35(4):270-4.
2001: Hans Hedelin; Lars Grenabo; Sten Holmäng
[Both major breakthroughs and stagnation in urology. Industry, together with clinicians, are responsible for most innovations].
Läkartidningen 2001;98(20):2440-4.
2001: Sten Holmäng; Sonny L Johansson
The nested variant of transitional cell carcinoma--a rare neoplasm with poor prognosis.
Scandinavian journal of urology and nephrology 2001;35(2):102-5.
2001: Sten Holmäng; Patrik Andius; Hans Hedelin; K Wester; C Busch; Sonny L Johansson
Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy.
The Journal of urology 2001;165(4):1124-8; discussion 1128-30.
2000: Ralph Peeker; M A Haghsheno; Sten Holmäng; Magnus Fall
Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study.
The Journal of urology 2000;164(6):1912-5; discussion 1915-6.
2000: Sten Holmäng
Follow-up of patients with noninvasive and superficially invasive bladder cancer.
Seminars in urologic oncology 2000;18(4):273-9.
2000: Sten Holmäng; Frank Aldenborg
Stage T1 adenocarcinoma of the urinary bladder--complete response after transurethral resection and intravesical bacillus Calmette-Guerin.
Scandinavian journal of urology and nephrology 2000;34(2):141-3.
2000: Sten Holmäng; Hans Hedelin; C Anderström; E Holmberg; Sonny L Johansson
Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period.
Scandinavian journal of urology and nephrology 2000;34(2):95-101.
1999: Sten Holmäng; Hans Hedelin; C Anderström; E Holmberg; C Busch; Sonny L Johansson
Recurrence and progression in low grade papillary urothelial tumors.
The Journal of urology 1999;162(3 Pt 1):702-7.
1999: Sonny L Johansson; G Borghede; Sten Holmäng
Micropapillary bladder carcinoma: a clinicopathological study of 20 cases.
The Journal of urology 1999;161(6):1798-802.
1998: Sten Holmäng; Hans Hedelin; C Anderström; E Holmberg; Sonny L Johansson
Long-term followup of a bladder carcinoma cohort: routine followup urography is not necessary.
The Journal of urology 1998;160(1):45-8.
1998: Sten Holmäng; G Borghede; Sonny L Johansson
Bladder carcinoma with lymphoepithelioma-like differentiation: a report of 9 cases.
The Journal of urology 1998;159(3):779-82.
1997: G Borghede; Hans Hedelin; Sten Holmäng; Karl-Axel Johansson; G Sernbo; Claes Mercke
Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;44(3):245-50.
1997: G Borghede; Hans Hedelin; Sten Holmäng; Karl-Axel Johansson; Frank Aldenborg; S Pettersson; G Sernbo; Arne Wallgren; Claes Mercke
Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;44(3):237-44.
1997: Sten Holmäng; Marianne Fehrling; Hans Hedelin
Palliative effect of intravesical bacillus Calmette-Guerin in elderly patients with advanced bladder carcinoma.
The Journal of urology 1997;158(3 Pt 1):812-3.
1997: Sten Holmäng; Hans Hedelin; C Anderström; Sonny L Johansson
Long-term followup of all patients with muscle invasive (stages T2, T3 and T4) bladder carcinoma in a geographical region.
The Journal of urology 1997;158(2):389-92.
1997: Sten Holmäng; Hans Hedelin; G Borghede; Sonny L Johansson
Long-term followup of a bladder carcinoma cohort: questionable value of radical radiotherapy.
The Journal of urology 1997;157(5):1642-6.
1997: Sten Holmäng; G Borghede; Sonny L Johansson
Primary signet ring cell carcinoma of the bladder: a report on 10 cases.
Scandinavian journal of urology and nephrology 1997;31(2):145-8.
1997: Sten Holmäng; Hans Hedelin; C Anderström; E Holmberg; Sonny L Johansson
The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study.
The Journal of urology 1997;157(3):800-3; discussion 804.
1997: Hans Hedelin; Sten Holmäng; L Wiman
[Outpatient treatment of bladder cancer--lower cost and satisfied patients].
Nordisk medicin 1997;112(2):48-51.
1996: Sten Holmäng; H Kleist; S Lundstam; G Borghede
Spontaneous perforation of the bladder after external beam radiotherapy for bladder carcinoma.
The Journal of urology 1996;155(2):645.
1996: Sten Holmäng; G Borghede
Early complications and survival following short-term palliative radiotherapy in invasive bladder carcinoma.
The Journal of urology 1996;155(1):100-2.
1995: Sten Holmäng; M Cano; Lars Grenabo; Hans Hedelin; Sonny L Johansson
Effect of indomethacin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced urinary tract carcinogenesis.
Carcinogenesis 1995;16(7):1493-8.
1995: Sten Holmäng; Hans Hedelin; C Anderström; Sonny L Johansson
The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years.
The Journal of urology 1995;153(6):1823-6; discussion 1826-7.
1995: Sten Holmäng; G Borghede; Sonny L Johansson
Primary small cell carcinoma of the bladder: a report of 25 cases.
The Journal of urology 1995;153(6):1820-2.
1994: Sten Holmäng; Frank Aldenborg; Hans Hedelin
Extirpation and fulguration of multiple superficial bladder tumour recurrences under intravesical lignocaine anaesthesia.
British journal of urology 1994;73(2):177-80.
1994: Sten Holmäng; Frank Aldenborg; Hans Hedelin
Multiple bladder biopsies under intravesical lignocaine anaesthesia.
British journal of urology 1994;73(2):160-3.
1993: P Mårin; Sten Holmäng; Claes M Gustafsson; L Jönsson; H Kvist; A Elander; J Eldh; Lars Sjöström; Göran Holm; Per Björntorp
Androgen treatment of abdominally obese men.
Obesity research 1993;1(4):245-51.
1993: Sten Holmäng; Lars Grenabo; Hans Hedelin; Jonas Hugosson; Silas Pettersson
Crystal adherence to rat bladder epithelium after long-term E. coli infection.
Scandinavian journal of urology and nephrology 1993;27(1):71-4.
1993: Sten Holmäng; P Mårin; Göran Lindstedt; H Hedelin
Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men.
The Prostate 1993;23(2):99-106.
1993: Sten Holmäng; G Lindstedt; P Mårin; Hans Hedelin
Serum concentration of prostate-specific antigen in relation to prostate volume in 50 healthy middle-aged men.
Scandinavian journal of urology and nephrology 1993;27(1):15-20.
1992: P Mårin; Sten Holmäng; L Jönsson; Lars Sjöström; H Kvist; Göran Holm; Göran Lindstedt; Per Björntorp
The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1992;16(12):991-7.
1992: Per Björntorp; P Mårin; Sten Holmäng
[Still too early for androgen therapy of abdominal obesity in males--inspite of good results].
Läkartidningen 1992;89(18):1568-9.
1991: Sten Holmäng; Lars Grenabo; Hans Hedelin; Eugen Yu-Hui Wang; Silas Pettersson
Influence of indomethacin on the adherence of urease-induced crystals to rat bladder epithelium.
The Journal of urology 1991;145(1):176-8.
1991: Eugen Yu-Hui Wang; Lars Grenabo; Hans Hedelin; Sten Holmäng; Silas Pettersson
Studies of urease-induced crystallisation in undiluted human urine using the Coulter counter technique.
Urological research 1991;19(3):171-5.